Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

323 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Interpretation of pertussis serologic tests.
Halperin SA. Halperin SA. Pediatr Infect Dis J. 1991 Oct;10(10):791-2. Pediatr Infect Dis J. 1991. PMID: 1945589 No abstract available.
Immune responses to pertussis vaccines concurrently administered with viral vaccines.
Halperin SA, Eastwood BJ, Langley JM. Halperin SA, et al. Ann N Y Acad Sci. 1995 May 31;754:89-96. doi: 10.1111/j.1749-6632.1995.tb44441.x. Ann N Y Acad Sci. 1995. PMID: 7625684 Clinical Trial. No abstract available.
Immunogenicity of a five-component acellular pertussis vaccine in infants and young children.
Halperin SA, Barreto L, Friesen B, Meekison W. Halperin SA, et al. Arch Pediatr Adolesc Med. 1994 May;148(5):495-502. doi: 10.1001/archpedi.1994.02170050053010. Arch Pediatr Adolesc Med. 1994. PMID: 7910089 Clinical Trial.
Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities.
Halperin SA, Barreto L, Eastwood BJ, Law B, Roberts EA. Halperin SA, et al. Arch Pediatr Adolesc Med. 1994 Nov;148(11):1220-4. doi: 10.1001/archpedi.1994.02170110106025. Arch Pediatr Adolesc Med. 1994. PMID: 7921131 Clinical Trial. No abstract available.
Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.
Halperin SA, Eastwood B, Barreto L, Mills E, Blatter M, Reisinger K, Bader G, Keyserling H, Roberts EA, Guasparini R, et al. Halperin SA, et al. Scand J Infect Dis. 1995;27(3):279-87. doi: 10.3109/00365549509019022. Scand J Infect Dis. 1995. PMID: 8539554 Clinical Trial.
Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age.
Halperin SA, Mills E, Barreto L, Pim C, Eastwood BJ. Halperin SA, et al. Pediatr Infect Dis J. 1995 Sep;14(9):792-7. doi: 10.1097/00006454-199509000-00012. Pediatr Infect Dis J. 1995. PMID: 8559630 Clinical Trial.
323 results
Jump to page
Feedback